Making a Difference in Cancer Care With You.
نویسنده
چکیده
1008 Saturday June 3, 1:15 PM to 4:15 PM; Hall D1 Ian Flinn, Richard van der Jagt, Julie E. Chang, Peter Wood, Tim E. Hawkins, David MacDonald, Judith Trotman, David Simpson, Kathryn S. Kolibaba, Samar Issa, Doreen M. Hallman, Ling Chen, John M. Burke. First-line treatment of iNHL or MCL patients with BR or R-CHOP/R-CVP: Results of the BRIGHT 5-year follow-up study. USOR Study # 7152 Abstract # 7500 Saturday June 3, 3:00 PM to 6:00 PM; S100bc 7500 Saturday June 3, 3:00 PM to 6:00 PM; S100bc David Jacob Andorsky, Abdulraheem Yacoub, Jason M. Melear, Morton Coleman, Kathryn S. Kolibaba, Heather Dawn Brooks, Jacob D. Bitran, Suzanne R. Fanning, Frederick Lansigan, Justin L. Ricker, Kenneth A. Foon, Dongfang Liu, Mary Llorente, Jiahui Li, Jeff Porter Sharman. Phase IIIb randomized study of lenalidomide plus rituximab (R2) followed by maintenance in relapsed/ refractory NHL: Analysis of patients with double-refractory or early relapsed follicular lymphoma (FL). USOR Study # 13064 Abstract # 7502 Saturday June 3, 3:00 PM to 6:00 PM; S100bc 7502 Saturday June 3, 3:00 PM to 6:00 PM; S100bc Jeff Porter Sharman, Danielle M. Brander, Anthony R. Mato, Suman Kambhampati, John M. Burke, Frederick Lansigan, Marshall T. Schreeder, Scott D. Lunin, Nilanjan Ghosh, Alexander Zweibach, Mikhail Shtivelband, Patrick M. Travis, Jason Claud Chandler, Kathryn S. Kolibaba, Peter Sportelli, Hari P. Miskin, Michael S. Weiss, Ian Flinn. Ublituximab and ibrutinib for previously treated genetically high-risk chronic lymphocytic leukemia: Results of the GENUINE phase 3 stud. USOR Study # 14206 Abstract # 7504 Saturday June 3, 3:00 PM to 6:00 PM; S100bc 7504 Saturday June 3, 3:00 PM to 6:00 PM; S100bc Sunil R. Hingorani, Andrea J. Bullock, Tara Elisabeth Seery, Lei Zheng, Darren Sigal, Paul S. Ritch, Fadi S. Braiteh, Mark Zalupski, Nathan Bahary, William Proctor Harris, Jie Pu, Carrie Aldrich, Sihem Khelifa, Xionghua W. Wu, Joaquina Baranda, Ping Jiang, Andrew Eugene Hendifar. Randomized phase II study of PEGPH20 plus nab-paclitaxel/gemcitabine (PAG) vs AG in patients (Pts) with untreated, metastatic pancreatic ductal adenocarcinoma (mPDA). USOR Study # 12237 Abstract # 4008 Sunday June 4, 8:00 AM to 11:00 AM; Hall D2 4008 Sunday June 4, 8:00 AM to 11:00 AM; Hall D2 Bolded text: Investigators affiliated with US Oncology Research, The US Oncology Network and/or McKesson Specialty Health. Learn More: Online: usoncology.com/research Email: [email protected] Phone: (281) 863-1000 US Oncology Research and The US Oncology Network are supported by McKesson Specialty Health. Copyright ©2017 McKesson Specialty Health. All rights reserved.
منابع مشابه
The Effect of Decision Aid's Pakage in Selected Treatment by Patients with Early Stage Breast Cancer and Decision making Outcomes
Background & Objectives: One of the basic principle of the protection of the patient, the patient's right to make decisions for their health. In this study, the effect of using decision aid's package was studied on choice of treatment and decision making outcomes in patients with early-stage breast cancer. Materials and Methods: This research is a clinical trial, performed on 30 patients with ...
متن کاملThe effect of Continuous Care Model on self-care in patients with colon cancer
Introduction: Colon cancer and its treatments have several signs and symptoms such as weakness, fatigue, lethargy, anorexia, nausea and vomiting, anemia, and eating disorders that self-care is essential to control in these patients. The aim of this study was to determine the effect of the continuous care model on self-care in patients with colon cancer. Methods: The present study was an experi...
متن کاملThe effect of palliative-care education on quality of life of women with breast cancer
Introduction: To provide systematic and public palliative care in Iran, education this care for breast cancer patients can improve the quality of life of these patients,So the present study was conducted to determine “the effect of educating palliative cares on the quality of life in breast cancer patients”. Method: In the present clinical trial 46 patients with breast cancer who referred to th...
متن کاملHighlights from the Gynecologic Oncology Track at the 2017 Annual Meeting of the American Society of Clinical Oncology
The American Society of Clinical Oncology (ASCO) 2017 Annual Meeting was held again at the McCormick Convention Center in Chicago, IL, USA. Over 37,500 international physicians, nurses, researchers, and exhibitors descended on the Windy City from June 2nd, 2017 through June 6th, 2017. This year's ASCO presidential theme, “Making a Difference in Cancer Care with You,” embodied the principle of t...
متن کاملP35: How to Manage Anxiety
Anxiety is a mental state that is elicited in anticipation of threat or potential threat. Sensations of anxiety are a normal part of human experience, but excessive or inappropriate anxiety can become an illness. Anxiety is part of the normal human experience. We may speculate that it served human survival during evolution by enhancing preparedness and alertness. However, anxious manifestations...
متن کاملمقایسه ی تاب آوری، مقابله با استرس و فاجعه سازی درد در بیماران مبتلا به سرطان وافراد عادی
Background: According to individual differences, patients suffering from cancer show different reactions. So, the purpose of this study is the comparison of resilience, coping style and pain catastrophizing in cancer patients and normal people. Methods: This study is ex post facto method. The target society of the research included all of the cancer patients in the hospital of Shiraz city th...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
دوره 35 24 شماره
صفحات -
تاریخ انتشار 2017